GlassScriptPhysician profile
Thampi John
NPI 1043244122
$37,577.74
in general payments reported to CMS, 2019-2025
36 companies · $3,182 in 2025
The $3,182 reported for 2025 was more than what 89% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,119 · 2020: $1,530 · 2021: $3,180 · 2022: $7,503 · 2023: $13K · 2024: $3,412 · 2025: $3,182.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Travel and Lodging: $7,450.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,796.21 |
| Travel and Lodging | $7,450.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $7,867.57 | 2019-2025 | Ensite Precision, Ensite, Aveir |
| Medtronic, INC. | $5,557.18 | 2021-2025 | Azure Xt Dr Mri Surescan, Micra, Cobalt Dr Mri Surescan |
| Boston Scientific Corporation | $5,489.48 | 2019-2025 | Rhythmia Mapping System, Watchman Flx, Lux-Dx Insertable Cardiac Monitor |
| Atricure, INC. | $4,396.57 | 2021-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Cvrx, INC. | $3,557.69 | 2019-2025 | Barostim Neo System |
| Biotronik INC. | $2,521.82 | 2019-2022 | |
| Cardiofocus, INC. | $1,230.70 | 2023 | Heartlight System |
| Medtronic Vascular, INC. | $1,125.09 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $1,053.00 | 2019-2024 | Camzyos, Eliquis |
| Elutia, INC. | $566.26 | 2019-2020 | |
| Cardiva Medical, INC. | $559.51 | 2023-2025 | Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Vvcs 6-12f, Savvywire |
| Novartis Pharmaceuticals Corporation | $446.74 | 2019-2023 | |
| Abiomed | $412.95 | 2019-2024 | Impella |
| Merck Sharp & Dohme LLC | $407.04 | 2021-2025 | Verquvo |
| Janssen Pharmaceuticals, INC | $340.50 | 2019-2023 | Xarelto |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $280.12 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $209.29 | 2019-2025 | Jardiance |
| Amgen INC. | $178.24 | 2019-2024 | Repatha |
| Kestra Medical Technology Services, INC. | $157.05 | 2023 | Assure Wcd |
| Scpharmaceuticals INC. | $147.78 | 2023-2024 | |
| Shockwave Medical, INC | $141.64 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Alnylam Pharmaceuticals INC. | $125.70 | 2025 | Onpattro |
| Bayer Healthcare Pharmaceuticals INC. | $125.00 | 2025 | |
| Biosense Webster, INC. | $116.08 | 2021-2024 | Qdot Micro Catheter |
| Bridgebio Pharma, INC. | $115.49 | 2025 | Attruby |
| Cordis US Corp. | $99.79 | 2024 | Mynx Venous Vcd |
| Philips North America LLC | $83.29 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $76.78 | 2019-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $48.53 | 2020-2022 | |
| Davol INC. | $23.76 | 2024 | Arista Ah Flexitip |
| Teleflex LLC | $22.96 | 2023 | Vascband |
| Baxter Healthcare | $21.29 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Novo Nordisk INC | $21.28 | 2024 | |
| Chiesi USA, INC. | $19.63 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $16.17 | 2024 | Uptravi, Opsumit |
| Convatec INC. | $15.77 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thampi John listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.